Robert Gaffey (@gaffey_robert) 's Twitter Profile
Robert Gaffey

@gaffey_robert

GI/hepatology fellow @MonteGastro | Graduate of Obesity Medicine @WeillCornell, @montefioreIM, Rutgers-@RWJMS and @AmherstCollege

ID: 1122177663978725377

calendar_today27-04-2019 16:36:18

61 Tweet

132 Followers

264 Following

Siddhartha Mukherjee (@drsidmukherjee) 's Twitter Profile Photo

Proud to be a signatory, along with over 100 other academic leaders, asking U.S. governors & business leaders to implement universal masking requirements #Masks4All up.fm/letter

Robert Gaffey (@gaffey_robert) 's Twitter Profile Photo

This is not unexpected, but extremely challenging. The only solutions go far beyond healthcare, and necessitate massive social and economic changes.

Jumaane Williams (@jumaane.bsky.social) (@jumaanewilliams) 's Twitter Profile Photo

I have to agree here. Waiting to act got is in trouble before. It was smart to open slowly. Even smarter to be cautious and adapt. #COVID19 #WearAMask

Robert Gaffey (@gaffey_robert) 's Twitter Profile Photo

One month in, and I am humbled and amazed by what I get to do! Just this week I got to do my first paracentesis working up new ascites and I became some people’s primary physician!

Robert Gaffey (@gaffey_robert) 's Twitter Profile Photo

Great discussion around MASH and metabolic surgery to improve outcomes from Ali Aminian and appreciate the brief discussion around alcohol-associated liver disease after bariatric surgery #obesityweek2023

Great discussion around MASH and metabolic surgery to improve outcomes from <a href="/Ali_Aminian_MD/">Ali Aminian</a> and appreciate the brief discussion around alcohol-associated liver disease after bariatric surgery #obesityweek2023
Juan Turnes (@jturnesv) 's Twitter Profile Photo

1/2 Study reveals #Retatrutide (triple GLP-1, GIP & glucagon agonist) significantly reduces liver fat in #MASLD patients 💉With 8 and 12 mg doses, over 80% of participants saw mean liver fat reductions 📉 hepatic steatosis resolved in over 85%! #TLM23 #LIvertwitter

1/2
Study reveals #Retatrutide (triple GLP-1, GIP &amp; glucagon agonist) significantly reduces liver fat in #MASLD patients

💉With 8 and 12 mg doses, over 80% of participants saw mean liver fat reductions

 📉 hepatic steatosis resolved in over 85%!

#TLM23 #LIvertwitter
Thomas Reiberger (@reibergerthomas) 's Twitter Profile Photo

Lukas Hartl presents our study on the effects of #BariatricSurgery at the #LiverMeeting #TLM23 AASLD 🔊 Shearwave Elastography #SWE 🔮 #Steatosis assessment by #CAP 🔪 3 months after surgery ✅pronounced weight loss ⬇️#LSM and #CAP decreased ? Longtterm effects

<a href="/hartl_md/">Lukas Hartl</a> presents our study on the effects of #BariatricSurgery at the #LiverMeeting #TLM23 <a href="/AASLDtweets/">AASLD</a> 

🔊 Shearwave Elastography #SWE
🔮  #Steatosis assessment by #CAP

🔪 3 months after surgery 
✅pronounced weight loss
⬇️#LSM and #CAP decreased

? Longtterm effects
Robert Gaffey (@gaffey_robert) 's Twitter Profile Photo

Had a great time at AASLD! Really enjoyed presenting on AUD and ALD after bariatric surgery and learning so much about emerging trends in MASH/MASLD!

Had a great time at AASLD! Really enjoyed presenting on AUD and ALD after bariatric surgery and learning so much about emerging trends in MASH/MASLD!
Robert Gaffey (@gaffey_robert) 's Twitter Profile Photo

So thrilled to have matched at Montefiore for GI/hepatology fellowship. So grateful to my mentors, who have supported me, and looking forward to returning to the Bronx!

Robert Gaffey (@gaffey_robert) 's Twitter Profile Photo

We wrote a review on GIP and GIP receptor modifying drugs! Thanks so much to Alpana Shukla for her mentorship and to Afua Takyi our coauthor! tandfonline.com/doi/full/10.10…